Publisher: Karger
E-ISSN: 1421-9794|52|1|46-49
ISSN: 0009-3157
Source: Chemotherapy, Vol.52, Iss.1, 2005-12, pp. : 46-49
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Is the Prophylactic Use of Hepatoprotectants Necessary in Anti-Tuberculosis Treatment?
Chemotherapy, Vol. 62, Iss. 5, 2017-05 ,pp. :
Treatment and Implications of Multidrug-Resistant Tuberculosis for the 21st Century
Chemotherapy, Vol. 45, Iss. 2, 1999-07 ,pp. :
Efficacy of Low-Dose Ofloxacin in the Treatment of Multidrug-Resistant Tuberculosis in Indonesia
Chemotherapy, Vol. 45, Iss. 2, 1999-07 ,pp. :